What is a biostimulator and how does it work?
A biostimulator is an injectable product that, once placed in the tissue, starts a controlled response around itself and aims to direct cells called fibroblasts to produce collagen. Its main purpose is not to add volume at the time of injection but to strengthen the skin’s and underlying tissue’s own support structure over time.
The firmness and resilience of the skin depend largely on the collagen fibres in the dermis. With age, collagen production slows, existing fibres thin and lose their organisation, and sun damage and smoking can speed this up. Biostimulators take a different route: the microspheres or polymer particles they contain start a mild, controlled response, similar to how the body reacts to a foreign material. Around the particles, fibroblasts are stimulated and new collagen formation is supported. As the particles are gradually broken down and cleared by the body, the new tissue that forms may take over part of the support. This is why the effect of a biostimulator is judged in the weeks and months after treatment, not on the day.
The term biostimulator describes a group of products with different active substances, not a single product. The group includes products based on calcium hydroxylapatite (CaHA), poly-L-lactic acid (PLLA), poly-D,L-lactic acid (PDLLA) and polycaprolactone (PCL), as well as hybrid products that combine one of these with hyaluronic acid. The classes differ in how early the effect starts, how many sessions are needed, which areas they can be used in and how long the body takes to break them down. In everyday speech these products are also called “biostimulator fillers” or “collagen vaccines”; for a proper assessment, the active substance of the product needs to be known. Which product suits you, or whether none does, is decided by the physician at an in-person examination.
What is the difference between CaHA, PLLA, PDLLA and PCL?
CaHA, PLLA, PDLLA and PCL are the four main active-substance classes of biostimulators. CaHA and PCL products also provide early support through a gel carrier, while PLLA and PDLLA products show their effect mostly through the collagen response over time. There is no general ranking between the classes; each suits a different situation.
Calcium hydroxylapatite (CaHA) is the synthetic form of a compound also found in the mineral structure of bone and teeth; Radiesse is a well-known example of this class. Polycaprolactone (PCL) is a synthetic polymer that is slowly broken down in the body; Ellansé is among the products mentioned in this class. In the well-known products of these two classes, the microspheres sit in a gel carrier based on carboxymethylcellulose. The gel provides volume and support straight after treatment and is absorbed over weeks, leaving the collagen response stimulated by the microspheres. For this reason CaHA and PCL products are mostly considered at support points such as the cheekbones, jawline and chin. CaHA can be seen on X-ray; with PCL products, the breakdown time is adjusted through different versions based on the length of the polymer chain.
Poly-L-lactic acid (PLLA) and poly-D,L-lactic acid (PDLLA) are polymers made from lactic acid and are broken down over time in the body into lactic acid. PLLA contains only the L form, while PDLLA contains both the L and D forms; Sculptra is mentioned as an example of the PLLA class, and Lenisna and Juvelook as examples of the PDLLA class. These products come as a powder and are reconstituted before use; the fullness in the first days comes from the fluid and fades within a few days. The real effect begins over weeks, and several sessions a few weeks apart are usually needed. PLLA is more often described for widespread volume loss, and PDLLA-based products more often for skin-quality uses. In hybrid products such as HArmonyCa, CaHA is supplied together with a hyaluronic acid gel.
What is the difference between a biostimulator and a hyaluronic acid filler?
A hyaluronic acid filler provides volume through the gel itself at the time of injection and can be dissolved with the enzyme hyaluronidase if needed. A biostimulator works largely through the body’s collagen response, gradually, and cannot be dissolved by the enzyme. The two groups are therefore not substitutes for each other; they are often used for different aims, and sometimes within the same plan.
Hyaluronic acid fillers consist of a gel made durable by cross-linking. The gel creates volume directly where it is placed; the result is usually visible during treatment and settles as swelling subsides over the first weeks. Hyaluronic acid fillers stand out where detailed shaping is needed in thin, delicate areas such as the lips, tear trough and nose, and where reversibility matters. That hyaluronidase can dissolve this gel offers an important safety option in an unwanted result or in an emergency such as vascular occlusion. On the other hand, a hyaluronic acid filler does not aim to change the skin’s own collagen structure to any marked degree; its effect depends largely on the gel remaining in the tissue.
With biostimulators, the aim is less to add a new material than to increase the body’s own supporting tissue. Because the change is gradual, it is not perceived as a sudden difference by those around you; however, seeing the result takes patience and regular check-ups. Since CaHA, PLLA, PDLLA and PCL are not dissolved by hyaluronidase, the choice of area, depth and amount is planned more cautiously, and they are generally not used in areas such as the lips and tear trough. In practice, the two groups often appear in the same plan: for example, a hyaluronic acid filler may be used for contour at a specific point, while a biostimulator targets skin quality and general support over a wider area. Which product is used where is decided at an in-person examination.
When is the effect of a biostimulator seen and how many sessions are needed?
The effect of a biostimulator starts in the first weeks for most people and becomes more noticeable over the few months after the last session. With CaHA and PCL products, early support from the gel is also seen. The number of sessions depends on the product, the area and how the tissue responds; some plans need a single session, others several.
The fullness seen in the first days after treatment mostly comes from the reconstitution fluid, the carrier gel and swelling from the procedure. With PLLA and PDLLA products this fullness fades within a few days and the face may look close to how it did before treatment for a while; this does not mean the product has had no effect. The collagen response develops over weeks, and most people notice the change more clearly in the second and third months. With CaHA and PCL products, the early support from the gel is gradually handed over to the collagen response as the gel is absorbed. Because collagen production proceeds at a different speed in each person, the result is usually assessed after a few months, and a decision about a new treatment is not rushed in the meantime.
With PLLA and PDLLA products, two or three sessions about four to six weeks apart are usually planned; some people may need fewer or more. When CaHA and PCL products are used for support, a single session is seen as enough in some plans, while dilute use for skin quality may be spread over several sessions. Before each session, the response to the previous treatment is assessed, an approach that helps reduce the risk of overcorrection. If attending check-ups between sessions will be difficult, for example if you travel from another city or country, the plan is built with this in mind from the start. Whether maintenance treatment is needed when the effect fades is discussed at follow-up.
What can a biostimulator address and what can it not?
Biostimulators may aim for gradual support in widespread mild to moderate volume loss, skin firmness and general skin quality. A biostimulator does not remove marked excess skin, does not lift advanced sagging in a surgical sense and is generally not used for detailed shaping in areas such as the lips or tear trough.
The contribution of a biostimulator can be most meaningful where there is widespread thinning and loss of support in the face and the skin still keeps a certain elasticity. Hollowing at the temples, flattening of the cheeks, slight vagueness of the jawline and thin, slack-looking skin are examples. In dilute use, supporting skin quality in areas such as the neck and décolletage can also be discussed; however, the licensed scope in Turkey is checked separately for each product and area. The degree of change varies with your age, skin structure, collagen response and lifestyle and cannot be promised in advance. Smoking and unprotected sun exposure can adversely affect the collagen response and how long the result lasts.
Biostimulators do not remove excess skin and do not reposition sagging tissue as a surgical facelift does; in advanced sagging, increasing the amount of product often makes the face heavier. They are generally not preferred in the lips, tear trough and very thin-skinned areas because of the risk of nodules. If an immediate, marked change in contour is wanted, hyaluronic acid fillers may be more suitable. Polynucleotides known as salmon DNA and hyaluronic acid skin boosters are sometimes mentioned under this heading too; however, they are not particle-based, do not provide volume or support, and are aimed mostly at the skin’s hydration, texture and quality. The difference is explained separately on the skin booster and salmon DNA pages.
Who may not be suitable for a biostimulator and what are the risks?
Biostimulators are not given during pregnancy and breastfeeding, when there is an active infection in the area, or with known hypersensitivity to a product component. A tendency to keloid scarring and autoimmune conditions are assessed separately. The main risks are swelling, bruising, nodules and, rarely, granuloma and vascular occlusion; because the product cannot be dissolved with an enzyme, planning is cautious.
Pregnancy and breastfeeding, active infection, cold sores, an acne flare or inflamed skin disease in the area, and known hypersensitivity to product components or to lidocaine are the main situations in which treatment is not given or is postponed. Because biostimulators work through the tissue’s response, a tendency to keloid or thick scarring, active autoimmune disease and treatments that affect the immune system are assessed with particular care. Bleeding disorders, use of blood thinners and an earlier filler of unknown content in the same area are also discussed at consultation. Biostimulators may not be a suitable option for people who expect a rapid, marked change or who see the result as equivalent to surgery.
Common effects are swelling, redness, tenderness and bruising, usually settling within days. A risk specific to biostimulators is nodules that can be felt or sometimes seen under the skin; these may be noticed weeks or months after treatment. More rarely, an inflammatory tissue response called a granuloma can develop. As with any injection, vascular occlusion is a rare but serious risk; blanching of the skin, a net-like purplish discolouration or steadily increasing pain needs assessment without delay, and any change in vision means going straight to an emergency department. Because biostimulators cannot be dissolved with an enzyme, safety rests on the right product, the right depth, the right technique and a measured amount.
Frequently asked questions
Is a biostimulator a type of filler?
A biostimulator is not a filler in the classic sense; its main aim is to stimulate the body’s own collagen production. However, because CaHA and PCL products also provide early support through a gel carrier, they are sometimes called “biostimulator fillers” in everyday speech. With PLLA and PDLLA products, the fullness in the first days comes from the reconstitution fluid and is temporary.
Is what people call a “collagen vaccine” a biostimulator?
“Collagen vaccine” is not a medical term and may be used for different treatments in different places. Often biostimulators such as PLLA are meant; sometimes mesotherapy or skin booster treatments are also called this. Asking about the active substance, product name and manufacturer of what is proposed is a reliable way to make clear what will be done.
Are salmon DNA (polynucleotide) and skin boosters also biostimulators?
Polynucleotides known as salmon DNA and hyaluronic acid skin boosters are sometimes called biostimulators in a broad sense. Unlike particle-based products such as CaHA, PLLA, PDLLA and PCL, however, they do not provide volume or support; their effect is more on the skin’s hydration, texture and quality. The two groups can be considered together for different purposes within one plan.
How long does the effect of a biostimulator last?
The effect of a biostimulator varies with the product class, the area, your age and your metabolism. Effects lasting about a year or somewhat longer are reported for CaHA products and up to two years for PLLA products such as Sculptra; for PCL products the duration depends on the version. These are average figures, and what to expect for you is discussed at consultation.
Can biostimulators be dissolved with hyaluronidase?
No. CaHA, PLLA, PDLLA and PCL cannot be dissolved with the enzyme hyaluronidase, which only breaks down hyaluronic acid. In hybrid products the enzyme affects only the hyaluronic acid component. For this reason, area, depth and amount are chosen cautiously in a biostimulator plan, and if a nodule or irregularity develops, the approach is decided by the physician case by case.
What is the difference between a biostimulator and devices such as HIFU or radiofrequency?
Biostimulators and devices such as HIFU or radiofrequency target the collagen response in different ways. With a biostimulator, a product placed in the tissue stimulates collagen production and may also provide some support. With devices, no product is given; controlled heat energy starts remodelling in the tissue and adds no volume. Whether one or both are considered depends on the type of problem.
What is the difference between a biostimulator and a thread lift?
A thread lift aims to support tissue slightly upwards with threads, usually dissolving ones, placed under the skin, whereas biostimulators do not lift tissue mechanically. Some threads also aim to stimulate a collagen response. The expectations, risks and limits of the two methods differ, and in advanced sagging neither replaces a surgical facelift.
Sources (5)
- Cureus (Flores Rodriguez et al.): Mechanisms of Cytokine Modulation and Inflammatory Cascade in Bio-stimulatory Skin Rejuvenation: A Comprehensive Literature Review of Poly-L-Lactic Acid, Calcium Hydroxyapatite, Polycaprolactone, and Poly-D, L-Lactic Acid (2026)
- Aesthet Surg J (Aguilera et al.): The Role of Calcium Hydroxylapatite (Radiesse) as a Regenerative Aesthetic Treatment: A Narrative Review (2023)
- J Drugs Dermatol (Vleggaar et al.): Consensus recommendations on the use of injectable poly-L-lactic acid for facial and nonfacial volumization (2014)
- Clin Cosmet Investig Dermatol (Christen, Vercesi): Polycaprolactone: How a Well-Known and Futuristic Polymer Has Become an Innovative Collagen-Stimulator in Esthetics (2020)
- Dermatol Surg (Goldie et al.; international panel incl. European experts): Global Consensus Guidelines for the Injection of Diluted and Hyperdiluted Calcium Hydroxylapatite for Skin Tightening (2018)
This content is for general information and does not replace a personal medical assessment.